124 related articles for article (PubMed ID: 22694787)
21. Dynamic targeting image-guided radiotherapy.
Huntzinger C; Munro P; Johnson S; Miettinen M; Zankowski C; Ahlstrom G; Glettig R; Filliberti R; Kaissl W; Kamber M; Amstutz M; Bouchet L; Klebanov D; Mostafavi H; Stark R
Med Dosim; 2006; 31(2):113-25. PubMed ID: 16690452
[TBL] [Abstract][Full Text] [Related]
22. Stereographic targeting in prostate radiotherapy: speed and precision by daily automatic positioning corrections using kilovoltage/megavoltage image pairs.
Mutanga TF; de Boer HC; van der Wielen GJ; Wentzler D; Barnhoorn J; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1074-83. PubMed ID: 18207657
[TBL] [Abstract][Full Text] [Related]
23. Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.
Jorgo K; Ágoston P; Major T; Takácsi-Nagy Z; Polgár C
Strahlenther Onkol; 2017 Jun; 193(6):452-458. PubMed ID: 28154882
[TBL] [Abstract][Full Text] [Related]
24. [Image-guided radiotherapy in prostate cancer: concepts and implications].
Créhange G; Martin E; Supiot S; Chapet O; Mazoyer F; Naudy S; Maingon P
Cancer Radiother; 2012 Sep; 16(5-6):430-8. PubMed ID: 22921961
[TBL] [Abstract][Full Text] [Related]
25. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.
Song S; Yenice KM; Kopec M; Liauw SL
Radiother Oncol; 2012 May; 103(2):270-4. PubMed ID: 21890224
[TBL] [Abstract][Full Text] [Related]
26. Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
Vesprini D; Catton C; Jacks L; Lockwood G; Rosewall T; Bayley A; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Nichol A; Skala M; Warde P; Bristow RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):608-16. PubMed ID: 22099034
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy.
Snir JA; Battista JJ; Bauman G; Yartsev S
Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):625-31. PubMed ID: 21482460
[TBL] [Abstract][Full Text] [Related]
30. Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT.
Van de Werf E; Lievens Y; Verstraete J; Pauwels K; Van den Bogaert W
Radiother Oncol; 2009 Oct; 93(1):137-40. PubMed ID: 19732984
[TBL] [Abstract][Full Text] [Related]
31. Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.
Schumacher LD; Dal Pra A; Hoffe SE; Mellon EA
Br J Radiol; 2020 Oct; 93(1114):20200028. PubMed ID: 32783629
[TBL] [Abstract][Full Text] [Related]
32. [Present and future of the image guided radiotherapy (IGRT) and its applications in lung cancer treatment].
Lefkopoulos D; Ferreira I; Isambert A; Le Péchoux C; Mornex F
Cancer Radiother; 2007; 11(1-2):23-31. PubMed ID: 17113331
[TBL] [Abstract][Full Text] [Related]
33. [Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].
Sbai A; Thariat J; Tachfouti N; Pan Q; Lagrange JL
Cancer Radiother; 2014 Dec; 18(8):740-4. PubMed ID: 25451671
[TBL] [Abstract][Full Text] [Related]
34. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Hsu A; Pawlicki T; Luxton G; Hara W; King CR
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
[TBL] [Abstract][Full Text] [Related]
35. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
36. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.
Gill S; Thomas J; Fox C; Kron T; Rolfo A; Leahy M; Chander S; Williams S; Tai KH; Duchesne GM; Foroudi F
Radiat Oncol; 2011 Oct; 6():145. PubMed ID: 22035354
[TBL] [Abstract][Full Text] [Related]
37. Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.
Middleton M; Frantzis J; Healy B; Jones M; Murry R; Kron T; Plank A; Catton C; Martin J
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1576-81. PubMed ID: 21074334
[TBL] [Abstract][Full Text] [Related]
38. A small footprint couch-top support device for image-guided radiotherapy of heavy patients.
Chen H; Morley K; Rodriguez R; Draeger E; Shafiq Ul Hassan M; Chen ZJ
J Appl Clin Med Phys; 2022 Dec; 23(12):e13788. PubMed ID: 36267043
[TBL] [Abstract][Full Text] [Related]
39. Image-Guided Radiotherapy for Pelvic Cancers: A Review of Current Evidence and Clinical Utilisation.
Webster A; Appelt AL; Eminowicz G
Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):805-816. PubMed ID: 33071029
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary application of an improved Demons deformable registration algorithm in tumor radiotherapy].
Zhou L; Zhen X; Lu W; Dou J; Zhou L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):40-5. PubMed ID: 22366002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
